Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial-Reference-Cited by-同舟云学术

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

Published:2021-06 Issue:6 Volume:22 Page:848-857
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Stratigos Alexander J,Sekulic Aleksandar,Peris Ketty,Bechter Oliver,Prey Sorilla,Kaatz Martin,Lewis Karl D,Basset-Seguin Nicole,Chang Anne Lynn S,Dalle Stèphane,Orland Almudena Fernandez,Licitra Lisa,Robert Caroline,Ulrich Claas,Hauschild Axel,Migden Michael R,Dummer Reinhard,Li Siyu,Yoo Suk-Young,Mohan Kosalai,Coates Ebony,Jankovic Vladimir,Fiaschi Nathalie,Okoye Emmanuel,Bassukas Ioannis D,Loquai Carmen,De Giorgi Vincenzo,Eroglu Zeynep,Gutzmer Ralf,Ulrich Jens,Puig Susana,Seebach Frank,Thurston Gavin,Weinreich David M,Yancopoulos George D,Lowy Israel,Bowler Timothy,Fury Matthew G

Funder

Sanofi US

Regeneron Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Management of high-risk and advanced basal cell carcinoma;Puig;Clin Transl Oncol,2015

2. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men;Wu;Am J Epidemiol,2013

3. Emerging trends in the treatment of advanced basal cell carcinoma;Migden;Cancer Treat Rev,2018

4. Efficacy and safety of vismodegib in advanced basal-cell carcinoma;Sekulic;N Engl J Med,2012

5. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial;Migden;Lancet Oncol,2015

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Non-Melanoma Skin Cancers;Hematology/Oncology Clinics of North America;2024-10

2. Therapeutic Advances in Advanced Basal Cell Carcinoma;Cancers;2024-09-04

3. Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma;Journal of Immunotherapy and Precision Oncology;2024-08-01

4. Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial;Future Oncology;2024-07-29

5. Emerging Indications for Neoadjuvant Systemic Therapies in Cutaneous Malignancies;Medical Sciences;2024-07-23